Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer.
de Miguel-Perez D, Ortega FG, Tejada RG, Martínez-Única A, Peterson CB, Russo A, Gunasekaran M, Cardona AF, Amezcua V, Lorente JA, Expósito Hernández J, Rolfo C, Serrano MJ. de Miguel-Perez D, et al. Among authors: exposito hernandez j. Biomark Res. 2023 Nov 15;11(1):98. doi: 10.1186/s40364-023-00544-y. Biomark Res. 2023. PMID: 37968730 Free PMC article.
Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients.
Delgado-Ureña M, Ortega FG, de Miguel-Pérez D, Rodriguez-Martínez A, García-Puche JL, Ilyine H, Lorente JA, Exposito-Hernandez J, Garrido-Navas MC, Delgado-Ramirez M, Serrano MJ. Delgado-Ureña M, et al. Among authors: exposito hernandez j. J Transl Med. 2018 Sep 6;16(1):251. doi: 10.1186/s12967-018-1624-2. J Transl Med. 2018. PMID: 30189880 Free PMC article.
Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients.
de Miguel Pérez D, Rodriguez Martínez A, Ortigosa Palomo A, Delgado Ureña M, Garcia Puche JL, Robles Remacho A, Exposito Hernandez J, Lorente Acosta JA, Ortega Sánchez FG, Serrano MJ. de Miguel Pérez D, et al. Among authors: exposito hernandez j. Sci Rep. 2020 Mar 4;10(1):3974. doi: 10.1038/s41598-020-60212-1. Sci Rep. 2020. PMID: 32132553 Free PMC article.
A Novel, Quick, and Reliable Smartphone-Based Method for Serum PSA Quantification: Original Design of a Portable Microfluidic Immunosensor-Based System.
Ortega FG, Gómez GE, González-Martinez C, Valero T, Expósito-Hernández J, Puche I, Rodriguez-Martinez A, Serrano MJ, Lorente JA, Fernández-Baldo MA. Ortega FG, et al. Among authors: exposito hernandez j. Cancers (Basel). 2022 Sep 16;14(18):4483. doi: 10.3390/cancers14184483. Cancers (Basel). 2022. PMID: 36139646 Free PMC article.
From precision medicine to imprecision medicine through limited diagnostic ability to detect low allelic frequency mutations.
Serrano MJ, Exposito-Hernández J, Guerrero R, Lopez-Hidalgo J, Aguilar M, Lorente JA, de Álava E, Garrido-Navas MC. Serrano MJ, et al. Among authors: exposito hernandez j. Transl Lung Cancer Res. 2020 Apr;9(2):180-183. doi: 10.21037/tlcr.2020.03.07. Transl Lung Cancer Res. 2020. PMID: 32420057 Free PMC article. No abstract available.
Clinical Outcomes of First-line Therapies for Advanced Non-Small Cell Lung Cancer: A Systematic Review of Trials Published Between 2010 and 2020.
García-Fumero R, Fernández-López C, Calleja-Hernández MÁ, Expósito-Ruiz M, Espín J, Expósito-Hernández J. García-Fumero R, et al. Among authors: exposito hernandez j. Am J Clin Oncol. 2023 Oct 1;46(10):433-438. doi: 10.1097/COC.0000000000001031. Epub 2023 Jul 31. Am J Clin Oncol. 2023. PMID: 37522643
Long-term Experience of LINAC Single-Dose Radiosurgery for Skull Base Meningiomas: A Retrospective Single-Center Study of 241 Cases.
Ortiz García IM, Rodríguez Valero P, Jorques Infante AM, Cordero Tous N, Expósito Hernández J, Olivares Granados G. Ortiz García IM, et al. Among authors: exposito hernandez j. Oper Neurosurg (Hagerstown). 2023 Dec 1;25(6):529-537. doi: 10.1227/ons.0000000000000887. Epub 2023 Sep 1. Oper Neurosurg (Hagerstown). 2023. PMID: 37655877
Trends in phase III randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer.
Fernández-López C, Expósito-Hernández J, Arrebola-Moreno JP, Calleja-Hernández MÁ, Expósito-Ruíz M, Guerrero-Tejada R, Linares I, Cabeza-Barrera J. Fernández-López C, et al. Among authors: exposito hernandez j, exposito ruiz m. Cancer Med. 2016 Sep;5(9):2190-7. doi: 10.1002/cam4.782. Epub 2016 Jul 23. Cancer Med. 2016. PMID: 27449070 Free PMC article. Review.
28 results